Our initial focus is crystallin biology. We are addressing the global need for a non-surgical and sight-restoring treatment for cataracts and presbyopia.

Learn more about Protein Misfolding Diseases.

We are committed to the discovery, development, and commercialization of treatments for protein misfolding diseases. We are particularly interested in genetically validated protein targets which are implicated in diseases of aging. 

Learn more about Our Science.